Profile data is unavailable for this security.
About the company
Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.
- Revenue in PLN (TTM)718.00k
- Net income in PLN54.47m
- Incorporated2017
- Employees132.00
- LocationScope Fluidics SAul. Ogrodowa 58, 9 pietroWARSZAWA 00-876PolandPOL
- Phone+48 223762114
- Websitehttps://scopefluidics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Poltreg SA | 0.00 | -24.56m | 127.31m | 33.00 | -- | 2.57 | -- | -- | -5.27 | -5.27 | 0.00 | 10.61 | 0.00 | 16.45 | -- | 0.00 | -25.87 | -9.02 | -29.62 | -10.18 | -- | -659.36 | -- | -854.23 | 2.65 | -- | 0.1365 | -- | -74.98 | -6.89 | -38.06 | -- | 83.47 | -- |
| Mabion SA | 14.81m | -59.30m | 132.53m | 204.00 | -- | 1.89 | -- | 8.95 | -3.67 | -3.67 | 0.9164 | 4.33 | 0.0988 | 8.10 | 27.25 | 72,602.94 | -39.56 | 0.5366 | -54.81 | 1.06 | -178.55 | 58.34 | -400.37 | 0.9643 | 0.2276 | -- | 0.04 | -- | -54.50 | -- | -115.35 | -- | 6.00 | -- |
| Molecure SA | 5.11m | -24.42m | 151.85m | 71.00 | -- | 1.70 | -- | 29.70 | -1.20 | -1.20 | 0.2493 | 4.34 | 0.0553 | -- | 7.01 | 50,119.41 | -26.42 | -3.15 | -27.53 | -3.30 | 51.48 | 93.34 | -477.67 | -15.45 | -- | -- | 0.0588 | -- | -40.47 | 278.20 | -10.27 | -- | 12.49 | -- |
| BIOTON SA | 295.81m | -2.82m | 352.04m | 363.00 | -- | 0.5946 | 9.96 | 1.19 | -0.0329 | -0.0329 | 3.45 | 6.90 | 0.3814 | 2.02 | 8.84 | 814,906.30 | -0.3638 | 0.5935 | -0.4325 | 0.7338 | 29.69 | 41.35 | -0.954 | 2.47 | 0.5186 | 1.64 | 0.0682 | 0.00 | 14.38 | 0.561 | -788.26 | -- | -26.87 | -- |
| Captor Therapeutics SA | 7.57m | -40.71m | 454.27m | 91.00 | -- | 13.59 | -- | 60.01 | -7.68 | -7.68 | 1.43 | 6.02 | 0.1387 | -- | 4.27 | 83,186.81 | -74.58 | -43.62 | -102.84 | -55.62 | 65.32 | 65.95 | -537.79 | -450.96 | -- | -- | 0.1029 | -- | 19.88 | -- | 45.56 | -- | 13.11 | -- |
| Scope Fluidics SA | 718.00k | 54.47m | 456.23m | 132.00 | 7.20 | 3.40 | 8.08 | 635.42 | 19.99 | 19.99 | 0.2633 | 42.35 | 0.0065 | 0.9348 | 10.80 | 11,396.83 | 49.25 | 54.44 | 52.79 | 58.98 | -178.69 | -440.53 | 7,586.77 | 33,272.12 | 12.82 | -- | 0.0212 | -- | -74.61 | -- | 448.26 | -- | 5.75 | -- |
| Ryvu Therapeutics SA | 69.80m | -118.69m | 581.47m | 294.00 | -- | 8.16 | -- | 8.33 | -5.13 | -5.13 | 3.02 | 3.08 | 0.212 | 12.29 | 7.31 | 237,411.60 | -36.05 | -23.64 | -48.51 | -27.84 | 70.86 | 29.35 | -170.05 | -208.85 | 2.26 | -- | 0.572 | -- | 66.38 | 83.01 | -20.98 | -- | -24.46 | -- |
| Selvita SA | 373.90m | -2.89m | 794.79m | 434.00 | -- | 2.51 | 15.05 | 2.13 | -0.1577 | -0.1577 | 20.37 | 17.23 | 0.5983 | 8.96 | 4.97 | 398,187.40 | -0.4629 | 5.76 | -0.5715 | 7.33 | 80.27 | 80.65 | -0.7737 | 8.57 | 0.8823 | 0.7538 | 0.3757 | -- | -1.73 | -- | -108.73 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 30 Jun 2025 | 80.00k | 2.53% |
| AgioFunds TFI SAas of 28 Jan 2026 | 16.69k | 0.53% |
| TFI PZU SAas of 30 Jun 2025 | 0.00 | 0.00% |
